126 related articles for article (PubMed ID: 38469735)
41. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
[TBL] [Abstract][Full Text] [Related]
42. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
[TBL] [Abstract][Full Text] [Related]
43. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
44. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
45. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
[TBL] [Abstract][Full Text] [Related]
46. Genomic characterisation of acral melanoma cell lines.
Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
[TBL] [Abstract][Full Text] [Related]
47. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
[TBL] [Abstract][Full Text] [Related]
48. A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.
Zhang C; Shen H; Yang T; Li T; Liu X; Wang J; Liao Z; Wei J; Lu J; Liu H; Xiang L; Yang Y; Yang M; Wang D; Li Y; Xing R; Teng S; Zhao J; Yang Y; Zhao G; Chen K; Li X; Yang J
Nat Commun; 2022 Nov; 13(1):7250. PubMed ID: 36433984
[TBL] [Abstract][Full Text] [Related]
49. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
Haugh AM; Zhang B; Quan VL; Garfield EM; Bubley JA; Kudalkar E; Verzi AE; Walton K; VandenBoom T; Merkel EA; Lee CY; Tan T; Isales MC; Kong BY; Wenzel AT; Bunick CG; Choi J; Sosman J; Gerami P
J Invest Dermatol; 2018 Feb; 138(2):384-393. PubMed ID: 28870692
[TBL] [Abstract][Full Text] [Related]
50. Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention.
Fan M; Pfeffer SR; Lynch HT; Cassidy P; Leachman S; Pfeffer LM; Kopelovich L
Oncotarget; 2013 Jan; 4(1):128-41. PubMed ID: 23371019
[TBL] [Abstract][Full Text] [Related]
51. Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation.
Veinalde R; Ozola A; Azarjana K; Molven A; Akslen LA; Doniņa S; Proboka G; Cēma I; Baginskis A; Pjanova D
Melanoma Res; 2013 Jun; 23(3):221-6. PubMed ID: 23546221
[TBL] [Abstract][Full Text] [Related]
52. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
53. Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma.
Kang HJ; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Int J Dermatol; 2020 Oct; 59(10):1249-1257. PubMed ID: 32720336
[TBL] [Abstract][Full Text] [Related]
54. NRAS mutations in primary and metastatic melanomas of Japanese patients.
Uhara H; Ashida A; Koga H; Ogawa E; Uchiyama A; Uchiyama R; Hayashi K; Kiniwa Y; Okuyama R
Int J Clin Oncol; 2014; 19(3):544-8. PubMed ID: 23739925
[TBL] [Abstract][Full Text] [Related]
55. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
56. Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.
Yang L; Dai J; Ma M; Mao L; Si L; Cui C; Sheng X; Chi Z; Yu S; Xu T; Yu J; Kong Y; Guo J
Eur J Cancer; 2019 Sep; 118():70-81. PubMed ID: 31325875
[TBL] [Abstract][Full Text] [Related]
57. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Puntervoll HE; Yang XR; Vetti HH; Bachmann IM; Avril MF; Benfodda M; Catricalà C; Dalle S; Duval-Modeste AB; Ghiorzo P; Grammatico P; Harland M; Hayward NK; Hu HH; Jouary T; Martin-Denavit T; Ozola A; Palmer JM; Pastorino L; Pjanova D; Soufir N; Steine SJ; Stratigos AJ; Thomas L; Tinat J; Tsao H; Veinalde R; Tucker MA; Bressac-de Paillerets B; Newton-Bishop JA; Goldstein AM; Akslen LA; Molven A
J Med Genet; 2013 Apr; 50(4):264-70. PubMed ID: 23384855
[TBL] [Abstract][Full Text] [Related]
58. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
[TBL] [Abstract][Full Text] [Related]
59. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
60. Expression signatures of early-stage and advanced medaka melanomas.
Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
